Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 33.9 CNY 5.94% Market Closed
Market Cap: 4.1B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Qingdao NovelBeam Technology Co Ltd stock under the Base Case scenario is 49.33 CNY. Compared to the current market price of 33.9 CNY, Qingdao NovelBeam Technology Co Ltd is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
49.33 CNY
Undervaluation 31%
Relative Value
Price
Q
Worst Case
Base Case
Best Case

Valuation Multiples

9.9
P/S
P/S
Price to Sales
9.9
vs History
67
vs Industry
11
Median 3Y
13.5
Median 5Y
11.6
Industry
2.2
Forward
6.5
More Details
32.7
P/E
P/E
Price to Earnings
32.7
vs History
67
vs Industry
14
Median 3Y
39.8
Median 5Y
36.8
Industry
21.8
Forward
18.5
More Details
29.1
P/OCF
P/OCF
Price to OCF
29.1
vs History
69
vs Industry
11
Median 3Y
40.6
Median 5Y
34.1
Industry
13.4
More Details
36.9
P/FCFE
P/FCFE
Price to FCFE
36.9
vs History
46
vs Industry
11
Median 3Y
41.3
Median 5Y
-25.9
Industry
19
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
86
vs Industry
23
Median 3Y
4.9
Median 5Y
4.9
Industry
2.1
More Details
8.7
EV/S
EV/S
Enterprise Value to Sales
8.7
vs History
67
vs Industry
12
Median 3Y
11.9
Median 5Y
10.3
Industry
2.3
Forward
5.7
More Details
13.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.6
vs History
69
vs Industry
13
Median 3Y
19.1
Median 5Y
16.5
Industry
4.8
More Details
26.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
26.3
vs History
69
vs Industry
10
Median 3Y
33.8
Median 5Y
30.2
Industry
11.4
Forward
14.3
More Details
26.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.3
vs History
69
vs Industry
14
Median 3Y
33.8
Median 5Y
30.2
Industry
15.5
Forward
23.6
More Details
25.4
EV/OCF
EV/OCF
Enterprise Value to OCF
25.4
vs History
69
vs Industry
13
Median 3Y
36.7
Median 5Y
29.6
Industry
13.3
More Details
40.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
40.1
vs History
51
vs Industry
9
Median 3Y
46
Median 5Y
39.6
Industry
17.1
More Details
4.4
EV/IC
EV/IC
Enterprise Value to IC
4.4
vs History
86
vs Industry
16
Median 3Y
8
Median 5Y
8.4
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Qingdao NovelBeam Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Qingdao NovelBeam Technology Co Ltd
SSE:688677
4.1B CNY 9.9 32.7 26.3 26.3
US
Abbott Laboratories
NYSE:ABT
223.1B USD 5.3 16.5 21.5 30.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Boston Scientific Corp
NYSE:BSX
150.3B USD 8.6 73.9 34.9 48.4
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
108B USD 3.3 25.4 13.6 19.2
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.7B USD 9.2 40.2 28.6 31.9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.